Background: The choice of general anaesthetics may affect postoperative cognitive outcomes. This study was designed to compare the potential impact of propofol-based vs sevoflurane-based general anaesthesia on the development of delayed neurocognitive recovery in older adults early after major cancer surgery. Methods: Older adults (aged !65 and <90 yr) who were scheduled to undergo major cancer surgery (!2 h) were randomised to receive either propofol-or sevoflurane-based general anaesthesia. Cognitive function was assessed before and 1 week after surgery with a battery of neuropsychological tests. Age-and education-matched non-surgical controls were recruited, and their cognitive functions were tested at comparable time intervals in order to adjust for learning effects from repeated tests. Delayed neurocognitive recovery was diagnosed according to the International Study of Postoperative Cognitive Dysfunction 1 definition. Results: From April 1, 2015 to October 15, 2016, 392 patients were enrolled and randomised. Of these patients, 387 completed the intervention and 30-day follow-up, and 379 completed 1-week neuropsychological tests. Fifty-nine control subjects were enrolled and completed repeated neuropsychological tests. The incidence of delayed neurocognitive recovery at 1 week was significantly lower in the propofol group [14.8% (28/189)] than in the sevoflurane group [23.2% (44/190); odds ratio¼0.577; 95% confidence interval, 0.342e0.975; P¼0.038]. Safety outcomes did not differ between the two groups. Conclusions: When compared with sevoflurane-based general anaesthesia, propofol-based general anaesthesia might decrease the incidence of delayed neurocognitive recovery in older adults after major cancer surgery. Clinical trials registration: NCT02662257; Chinese Clinical Trial Registry (identifier: ChiCTR-IPR-15006209).
Anaesthesia and surgery have been associated with cognitive disorders, including delirium and delayed neurocognitive recovery [postoperative cognitive dysfunction (POCD) occurring within the 1st month after surgery].
1e3 Unlike delirium, the diagnostic criteria for delayed neurocognitive recovery or early POCD have varied widely. 4, 5 In an international multicentre study [International Study of POCD (ISPOCD1)], the incidence of POCD was 25.8% at 1 week, 9.9% at 3 months, 6 and 1% at 1e2 yrs in older adults after major non-cardiac surgery. 7 The occurrence of delayed neurocognitive recovery or POCD is associated with worse outcomes, including an increased risk of leaving labour market prematurely, dependency on social transfer payments, and mortality. 8, 9 Propofol and sevoflurane are commonly used general anaesthetics in clinical practice. It has been suggested that under certain circumstances, anaesthetic agents might have neuroprotective effects against various neural injuries. 10 In contrast, preclinical studies have demonstrated that inhalational anaesthetics may be neurotoxic by, for example causing amyloidbeta deposition, 11 whilst propofol may produce neuronal cell death in the developing rat brain. 12 Depending on the circumstances, it is possible that anaesthetic agents could be neuroprotective, neuroprotoxic, or have neither beneficial nor deleterious effects on the brain. 11e15 The effects of different general anaesthetics on the brain and its function in different patient populations and clinical contexts remain uncertain. Choice of anaesthetics may affect cognitive outcome after surgery, but results from clinical studies have been conflicting. Some studies have reported worse cognitive outcomes after inhalational than after intravenous anaesthesia. 16e19 Other studies have found no significant differences with respect to cognitive outcomes between propofol and sevoflurane anaesthesia. 20, 21 In contrast, yet another study found better cognitive outcome after sevoflurane than after propofol anaesthesia in patients with impaired cerebral oxygenation. 22 The reasons behind these conflicting findings are unknown. Differences in methods for assessing cognitive outcomes could play a role. For example, the Mini-Mental State Examination and the Montreal Cognitive Assessment have been used in some studies, 16, 20, 22 whereas more rigorous neuropsychological test batteries have been conducted in other studies. 17,19À21,23 Inclusion in research studies of a non-surgical control group is recommended to enable adjustment for learning effects from repeated neurocognitive tests. 19, 24 Lack of a control group has been a limitation in many previous studies. Another important limitation has been that the 'depth of anaesthesia' was not necessarily controlled or reported. 16e23 Hence, it was unclear
whether and to what extent the different cognitive outcomes represented an effect of different anaesthetics or simply different anaesthetic depths between groups. 25, 26 Taking together all the disparate findings in previous research, there is currently insufficient evidence to inform the choice of general anaesthetic agent with respect to effect on neurocognitive recovery.
The aim of the current study was to compare the effect of propofol vs sevoflurane on the incidence of delayed neurocognitive recovery in older adults undergoing major cancer surgery, with age-and education-matched non-surgical controls included to factor in learning effects from repeated neurocognitive tests.
Methods

Study design and ethics
This was a pre-specified analysis of one centre data from a randomised controlled trial performed in 17 centres. The protocol of the trial was approval by the Clinical Research Ethics Committee of Peking University First Hospital [Beijing, China 2015 (869)] and was designed to compare the impact of sevoflurane-based vs propofol-based general anaesthesia on early and long-term outcomes in elderly patients after cancer surgery. 27 All patients who were recruited and underwent surgery in one centre (Peking University First Hospital) during the study period were included in the present study. Written informed consents were obtained from patients or their legal representatives in the ward the day before surgery (or on Friday for patients who would undergo surgery the following Monday). The study was registered with Chinese Clinical Trial Registry (www.chictr.org.cn; ChiCTR-IPR-15006209) and ClinicalTrials.gov (NCT02662257). Neurocognitive recovery on the 7th postoperative day, one of the pre-specified outcome measures, was assessed and analysed in the current study.
Participants
Potential participants were screened the day before surgery. Patients were included if they met all the following criteria: (1) age !65 and <90 yr; (2) primary cancer without any radio-or chemotherapy before surgery; and (3) scheduled to undergo surgery for cancer with an expected duration !2 h, under general anaesthesia. Patients were excluded if they met any of the following criteria: (1) preoperative history of schizophrenia, epilepsy, Parkinsonism, or myasthenia gravis; (2) inability to communicate in the preoperative period because of coma, profound dementia, language barrier, or incapacity from severe disease; (3) critical illness (preoperative ASA physical status classification > 3), severe hepatic dysfunction (ChildePugh class C), or severe renal dysfunction (undergoing dialysis before surgery); or (4) neurosurgery. To correct for the practice effect of repeatedly administered neuropsychological tests, a group of non-surgical control subjects was enrolled from family members or friends of patients. The inclusion and exclusion criteria were the same as
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Randomisation
A biostatistician, who was independent of data management and statistical analyses, generated random numbers (in a 1:1 ratio, with a block size of 4) using the SAS 9.2 software (SAS Institute, Cary, NC, USA). The results of randomisation were sealed in sequentially numbered envelopes and stored at the site of the study. During the study period, consecutively recruited patients received either propofol-based general anaesthesia (propofol group) or sevoflurane-based general anaesthesia (sevoflurane group) according to the random number allocation provided by a study coordinator. For each recruited patient, intraoperative data were collected by anaesthesiologists. Preoperative interview and postoperative follow-up was performed by investigators (YZ, YXZ, and GJS) who did not participate in anaesthesia and perioperative patient care and had been trained before the study. Anaesthesiologist(s) and investigator(s) did not communicate with each other regarding patients' information while collecting data. Both patients and investigators were blinded to study group assignment.
Anaesthesia and perioperative care
No preoperative anxiolytic medication was administered. Intraoperative monitoring include electrocardiogram, noninvasive blood pressure, oxygen saturation, bispectral index (BIS), end-tidal partial pressure of carbon dioxide, end-tidal concentration of sevoflurane, nasopharyngeal temperature, and urine output. Intra-arterial blood pressure and central venous pressure were monitored when clinically indicated.
Anaesthesia was induced intravenously with midazolam, remifentanil and/or sufentanil, propofol, and rocuronium or cisatracurium. For patients in the propofol group, anaesthesia was maintained with a propofol infusion. For patients in the sevoflurane group, anaesthesia was maintained with inhaled sevoflurane. The BIS value was maintained between 40 and 60 by adjusting the infusion rate of propofol or the inhaled concentration of sevoflurane, according to group assignment. For patients in both groups, analgesia was provided with remifentanil and/or sufentanil; neuromuscular block was achieved with rocuronium or cisatracurium.
Postoperative analgesia during the first 3 days was provided with a patient-controlled analgesia pump, which was established with morphine (0.5 mg ml À1 ) or sufentanil (1e2 mg ml À1 ), programmed to deliver a 2-ml bolus with a lockout interval of 6e10 min and a background infusion of 1 ml h À1 . Patients were transferred to the ICU when needed; otherwise, they were transferred to the PACU for at least 30 min, and then to the general wards.
During the perioperative period, vasoactive drugs were administered for the purpose of maintaining haemodynamic stability. Blood transfusion and other drugs (including glucocorticoids) were administered according to usual clinical practice. When patients were admitted to the ICU, consultant intensivists made decisions regarding extubation (for patients with tracheal tubes) and ICU discharge. For patients on the general wards, consultant surgeons determined when hospital discharge was appropriate.
Data collection
Baseline data included patient characteristics (age, sex, education level, and body mass index), surgical diagnosis, and preoperative comorbidities. Severities of comorbid diseases were evaluated with the Charlson comorbidity index 28 and
New York Heart Association functional classification. Fitness and functionality before surgery were assessed with the ASA physical status classification and Barthel index (BI; scores range from 0 to 100, with higher scores indicating better ability to perform functions of daily life, such as bathing and dressing). Cognitive function was evaluated with Mini-Mental State Examination (MMSE; scores range from 0 to 30, with higher scores indicating better cognitive function).
Intraoperative data included type of surgery, durations of anaesthesia and surgery, types and doses of anaesthetic drugs, types and doses of glucocorticoids, estimated bleeding, types and volumes of blood products transfused, types and volumes of fluids infused, and BIS values and blood pressure measurements, both of which were stored with the anaesthesia information system in a real-time manner.
During the postoperative period, patients were followed up twice daily (between 8e10 AM in the morning and 6e8 PM in the afternoon) for 7 days and then weekly until the 30th day after surgery. Collected data included ICU admission, numerical rating scale (NRS; ranging from 0 to 10) for pain during the first 3 days, use of analgesic and sedative drugs within 7 days, occurrence of postoperative complications within 30 days, length of stay in hospital after surgery, and all-cause 30-day mortality. For patients who were admitted to the ICU after surgery, the worst score of Acute Physiology and Chronic Health Evaluation II (APACHE II, scores range from 0 to 71 with higher scores indicating more severe illness) within 24 h, time to extubation (for those with tracheal tubes in place), and length of ICU stay were also recorded. Total opioid consumption over 7 days (from the beginning of anaesthesia to the 7th day after surgery) was converted to intravenous morphine equivalents. 29 For those alive at 30 days, cognitive function was assessed with Telephone Interview for Cognitive Statusmodified (TICS-m; scores range from 0 to 48, with higher scores indicating better function). Postoperative complications were defined as newly occurring medical conditions that were harmful for patients' recovery and required therapeutic intervention. The occurrence of adverse events was monitored from the beginning of anaesthesia until 24 h after surgery. Hypotension was defined as systolic blood pressure < 90 mm Hg or a decrease of systolic blood pressure of >30% from baseline (average value in the ward before surgery), and required intravenous vasoactive and/or inotropic drugs. Hypertension was defined as systolic blood pressure >180 mm Hg or an increase of systolic blood pressure of >30% from baseline, and as requiring intravenous antihypertensives. Bradycardia was defined as heart rate <50 beats min À1 or a decrease of >30% from baseline, and as requiring chronotropic treatment such as atropine. Tachycardia was defined as heart rate >120 beats min À1 or an increase of >30% from baseline, and as requiring anti-tachycardia treatment such as esmolol. Emergence agitation was defined as Richmond AgitationeSedation Scale (RASS) !þ1 within 30 min after extubation. 30 Arrhythmia was diagnosed by electrocardiographic monitoring, and according to requirement for anti-arrhythmia treatment.
Neurocognitive assessment
Neuropsychological tests for both patients and control subjects were carried out the day before and 1 week after surgery in the hospital ward (or at matched time points for control subjects). The investigator (GJS) who performed the assessment was trained on neuropsychological test administration and was not involved in perioperative care of patients. Seven tests with nine subscales were administered (Supplementary Table S1 ). 31 Delayed neurocognitive recovery was diagnosed using the ISPOCD1 definition, which has gained acceptance in the postoperative setting. 6, 32 To quantify the learning or practice effect, baseline scores were compared with 1-week test scores to obtain the average practice effects (DXcontrol) and their standard deviations [SD(DXcontrol)] in control subjects. For each patient, baseline scores were compared with 1-week postoperative test scores, the average practice effects were subtracted from these changes (DX), and divided the results by the control subject SDs to obtain a Z score for each test. The test results were adjusted so that a negative Z score indicated deterioration from the baseline test. The Z scores of all tests in an individual patient were then summarised ( P Z) and divided by the SDs for this sum of Z scores in the control subjects [SD( P Zcontrol)], creating a global Z score (Zcombined). A patient was defined as having delayed neurocognitive recovery when two Z scores in individual tests or the combined Z score were e1.96 or less. 
Statistical analysis
Sample size calculation
In previous studies, the incidence of delayed neurocognitive recovery in comparable patient populations was about 30% at 1 week after surgery or at hospital discharge. 6, 9 According to published studies, the incidences of delayed neurocognitive recovery were reduced by 66.7% 19 and 33.3% 20 when comparing propofol vs sevoflurane anaesthesia in patients undergoing major non-cardiac surgery, respectively. We assumed that the incidence of delayed neurocognitive recovery would be reduced by up to 50% in the propofol group. With significance set at 0.05 and power set at 90%, the sample size required to detect a 50% reduction (from 30%) was 322 patients. Taking into account a loss-to-follow-up rate of about 10%, we needed to enroll 358 patients. Sample size was calculated with the PASS 11.0 software (Stata Corp. LP, College Station, TX, USA).
Outcome analysis
The primary endpoint was the incidence of delayed neurocognitive recovery at 1 week after surgery. Secondary endpoints included the proportion of patients requiring ICU admission after surgery, the length of stay in hospital after surgery, the occurrence of other complications within 30 days, cognitive function (TICS-m score) of 30-day survivors, and the 30-day mortality. Continuous variables were analysed using the unpaired ttest or ManneWhitney U-test. Categorical variables were analysed using the c 2 test, continuity correction c 2 test, or
Fisher exact test; odds ratios (ORs) were calculated by logistic regression analysis. Time-to-event results were compared using the KaplaneMeier survival analysis, with the difference between groups tested by the log-rank test and hazard ratio (HR), calculated by Cox regression analysis. Outcome and safety data were analysed in the intent-to-treat population. We also performed per-protocol analysis for the primary endpoint. Two-tailed tests were performed whenever appropriate, and P-values of <0.05 were considered of statistical significance. The SPSS 14.0 for Windows (SPSS Inc., Chicago, IL, USA) software was used for all statistical analyses.
Results
Subject characteristics
Between April 1, 2015 and October 15, 2016, 392 subjects were enrolled and randomised; of these, 387 completed the interventions and 30-day follow-up, and 379 completed followup neuropsychological tests at 1 week after surgery (Fig. 1) .
The final follow-up of the last randomised subject was performed on November 19, 2016. Results were reported For all enrolled subjects and for those who completed postoperative neuropsychological tests, the mean BIS values during anaesthesia were lower in the propofol group than in the sevoflurane group (P¼0.002). The proportion of intraabdominal surgery was lower (the proportion of intrathoracic surgery was higher) in the propofol group than in the sevoflurane group (P<0.001). As expected, the propofol consumption was much higher in the propofol group than in the sevoflurane group (P<0.001). Other baseline and perioperative variables were comparable between the two groups (Tables 1 and 2, Supplementary Table S2) .
Cognitive function of subjects and control subjects
During the study period, 59 control subjects were enrolled and completed both baseline and 1-week follow-up neuropsychological tests. Comparison between subjects and control subjects who completed 1-week follow-up tests showed that variables including age, sex, educational level, and the time interval to follow-up tests were similar in controls and surgical subjects. When compared with control subjects, the incidence of cognitive decline at 1-week follow-up was higher in subjects [19. 0% (72/379) vs 6.8% (4/59) in control subjects, P¼0.020] ( Table 3,  Supplementary Table S3) . The NRS pain scores at rest were significantly lower in the propofol group than in the sevoflurane group in the first and second morning after surgery (P¼0.013 and 0.015, respectively). There were no significant differences between the two groups regarding other clinical outcomes after surgery including other complications within 30 days. No patient died within 30 days (Table 4, Supplementary Table S4 ).
Safety analysis
The proportion of subjects who developed tachycardia during anaesthesia was significantly lower in the propofol group than in the sevoflurane group [2.1% (4/195) with propofol vs 6.3% (12/192) with sevoflurane, P¼0.038]. The occurrence of other adverse events did not differ significantly between the two groups ( Table 5 ).
Discussion
Our study found that, in older adults undergoing major cancer surgery, propofol-based general anaesthesia decreased the incidence of delayed neurocognitive recovery at 1 week after surgery when compared with sevoflurane-based general anaesthesia. It also decreased the occurrence of perioperative tachycardia.
Older adults are at increased risk of developing cognitive dysfunction after major surgery. 6, 8, 9, 32 Cancer is one of the most common indications for surgery in older adults. 33 Bearing this in mind, older patients with cancer were recruited, and our results showed that delayed neurocognitive recovery manifested in 19.0% of these patients at 1 week after surgery. This was in line with the previous reported incidence of POCD (from 9.1% to 25.8%) in cohort studies of non-cardiac patients.
4À6,34
Our trial results revealed that delayed neurocognitive recovery developed in 23.2% of patients in the sevoflurane group; this was also in line with the reported incidence (from 20% to 33.3%) in patients after sevoflurane anaesthesia in other trials. 17, 20, 21 The underlying mechanisms leading to delayed neurocognitive recovery are not clear, but may include reduced cognitive reserve in the elderly, potential neurotoxic effects of anaesthetics, and inflammatory response to surgical stimuli. 35 The putative mechanisms underlying less delayed neurocognitive recovery after propofol anaesthesia may include the following. First, volatile general anaesthetics may produce neurotoxic effects such as amyloid-beta accumulation, which may then lead to cognitive impairment; these effects are not observed with propofol. 36, 37 Importantly, in a small clinical study, propofol did not change the biomarkers of Alzheimer's disease when compared with isoflurane. 14 This is in contrast to a pre-clinical study in which propofol was reported to increase tau phosphorylation. 38 Second, neuroinflammatory response provoked by surgical stress might play an important role in the development of postoperative cognitive decline. 39 Volatile anaesthetics tend to increase the expression of pro-inflammatory cytokines, whereas propofol does not produce such effects and can even attenuate the impact of volatile anaesthetics. 18, 36, 40 However, negative results regarding volatile anaesthetics and inflammation have also been reported. 15 Third, pain intensity is less severe after propofol anaesthesia than after inhalational anaesthesia, 41, 42 which was also the case in the present study and might have mitigated cognitive decline after surgery. 43 However, the differences in pain scores between groups in our study were small, and these are unlikely to have clinical significance. Taking all the evidence together, whether or not anaesthetic agents may contribute to the development of delayed neurocognitive recovery remains controversial. Furthermore, the potential confounding effects of opioids cannot be ignored. 47e50 Therefore, the roles and the mechanisms of anaesthetic agents such as propofol and sevoflurane on postoperative cognitive outcomes warrant further study.
In the present study, tachycardia occurred during anaesthesia and was more frequent in the sevoflurane group than in the propofol group. Potential mechanisms underlying this phenomenon are not clear. Sevoflurane does not sensitise myocardium to catecholamines 51 and has little effect on the cardiac conduction system. 52 However, there are reports of sevoflurane-induced arrhythmia during anaesthesia. 53, 54 It is also possible that this was a spurious finding. Our study had several advantages when compared with previous trials investigating the effects of propofol vs inhalational anaesthesia on early postoperative cognitive outcomes. First, the neuropsychological test battery which includes seven tests with nine subscales was chosen according to the consensus on assessment of postoperative neurobehavioral outcomes, and covers the cognitive domains that are frequently affected after surgery. 55 Second, a group of control subjects was enrolled and was well matched with patients. Delayed neurocognitive recovery was diagnosed according to the definition of the ISPOCD1 study, 6 which is widely accepted as a valid approach. 32 Nonetheless, cognitive dysfunction can be falsely diagnosed, as evidenced by the apparent 6.8% incidence of 'cognitive dysfunction' at 1-week in our control subjects. Third, the sample size was relatively large and the effect size was clinically meaningful. There are also several limitations of the present study. First, this predefined analysis was performed using data from older adults recruited in only one centre. The generalisability of our results can legitimately be questioned. Second, the 'detrimental' effects of sevoflurane may be underestimated because propofol was also used during induction of The relevance of this observation to the outcomes of the study is uncertain. Fourth, many different surgeries were included in this study. Propofol might be beneficial compared with sevoflurane in (unknown) select surgeries. Fifth, delirium and delayed neurocognitive recovery might represent distinct or overlapping clinical entities. How these two anaesthetic agents affect the incidence of delirium is unknown. Last, the sample size was calculated to detect the difference of delayed neurocognitive recovery at 1 week after surgery. We do not know if a decreased incidence of delayed neurocognitive recovery is associated with any improvements in any of the other early outcomes. Long-term outcomes including cognitive function, quality of life, and survival length will be investigated. 27 The current study provides impetus for further research examining the effects of various anaesthetic agents on postoperative cognitive outcomes.
Conclusions
Compared with sevoflurane-based general anaesthesia, propofol-based general anaesthesia reduced the incidence of delayed neurocognitive recovery in elderly patients at 1 week after major cancer surgery. The impacts of intravenous vs inhalational anaesthesia on long-term outcomes are currently under investigation. Table 5 Safety outcomes. Data are presented as number of patients (%). PONV, postoperative nausea and vomiting *Systolic blood pressure < 90 mm Hg or a decrease of systolic blood pressure of >30% from baseline (average value in the ward), and required intravenous dopamine, norepinephrine, epinephrine, or dobutamine. yHeart rate < 50 beats min À1 or a decrease of >30% from baseline (average value in the ward), and required intravenous atropine. zSystolic blood pressure >180 mm Hg or an increase of systolic blood pressure of >30% from baseline (average value in the ward), and required intravenous urapidil or nicardipine. ¶Heart rate >120 beats min À1 or an increase of >30% from baseline (average value in the ward), and required intravenous esmolol. 
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